Lexaria Bioscience Corp.
LEXX | NASDAQ
$3.42
+$0.18 (+5.56%)
At close: Sep 21, 2026, 4:00 PM ET
$3.42
$0 (+0.15%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Market Data
Market Cap $5.66M
Enterprise Value $2.13M
Beta 0.34
Average Volume 26.08K
Shares Outstanding (Diluted) 1.65M
Shares Change YoY 35.56%
Institutional Ownership 6.10%
Exchange NASDAQ
ISIN US52886N6040
Price Performance
Price Change 1M -68.8%
Price Change 3M -59.8%
Price Change 6M -70.6%
Price Change YTD -65.1%
Price Change 1Y -83.1%
Price Change 3Y -75.5%
Price Change 5Y -96.7%
1M CAGR (ann.) -34.9%
1Y CAGR (ann.) -81.3%
5Y CAGR (ann.) -48.0%
All-Time CAGR -40.7%
Valuation
PE Ratio -0.64
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.07
PS Ratio 29.17
Forward PS 4.00
PB Ratio 1.19
P/FCF Ratio -0.75
P/Adj. FCF Ratio -0.72
P/OCF Ratio -0.76
EV/Sales 10.98
EV/EBIT -0.28
EV/EBITDA -0.28
EV/FCF -0.28
Earnings Yield -155.6%
FCF Yield -132.5%
Adj. FCF Yield -139.0%
Financial Health
Net Cash $3.62M
Total Debt $86.71K
Cash & Short-Term Investments $3.62M
Total Assets $4.78M
Current Ratio 10.60
Quick Ratio 10.60
Debt / Equity Ratio 0.02
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -85.63
Interest Coverage 0.00
Altman Z-Score -16.66
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -3973.2%
EBITDA Margin -3958.1%
Net Profit Margin -3985.6%
FCF Margin -3866.6%
Adj. FCF Margin -4054.9%
SBC / Revenue 188.4%
SBC Impact (per share) -4.9%
Returns
Return on Assets -161.7%
Return on Equity -160.7%
Return on Invested Capital -174.0%
Return on Capital Employed -175.3%
Return on Tangible Assets -174.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -14.2%
Revenue CAGR 5Y -25.1%
Revenue CAGR 10Y 18.1%
EPS CAGR 3Y 8.6%
EPS CAGR 5Y 28.4%
EPS CAGR 10Y 13.3%
FCF CAGR 3Y -17.7%
FCF CAGR 5Y -14.4%
FCF CAGR 10Y -16.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y 159.3%
Revenue Growth Next 3Y 612.5%
Earnings Date Oct 27, 2026
EPS Estimate (next Q) -$0.90
EPS Growth Est (next Q) -57.1%
Revenue Est (next Q) $50K
Revenue Growth Est (next Q) -75.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1.50
Price Target Upside -56.1%
Cash Flow
Operating Cash Flow $-7.43M
Free Cash Flow $-7.5M
Adj. Free Cash Flow $-7.87M
FCF Per Share -$4.55
OCF Per Share -$4.49
OCF/S Ratio -3827.6%
Income Statement
Revenue $194K
Gross Profit $194K
Operating Income $-7.71M
EBITDA $-7.68M
Net Income $-7.73M
EPS (Diluted) -$5.32
Revenue / Employee $27.71K
Profit / Employee $-1.1M
Employees 7
Add to Watchlist
Select watchlists to add or remove LEXX